Biochemistry of cardiomyopathy in the mitochondrial disease Friedreich's ataxia

Biochemical Journal

Volumn 453, Issue 3, 2013, Pages 321-336

  Lane, Darius J R ^a   Huang, Michael Li Hsuan ^a   Ting, Samantha ^a   Sivagurunathan, Sutharshani ^a   Richardson, Des R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Apoptosis; Autophagy; Cardiomyopathy; Frataxin; Friedreich's ataxia; Integrated stress response

Indexed keywords

CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; FRATAXIN; HYPOXIA INDUCIBLE FACTOR 2ALPHA; INITIATION FACTOR 2ALPHA; IRON; IRON BINDING PROTEIN; METHYLENETETRAHYDROFOLATE DEHYDROGENASE; PROTEIN P53;

AMINO ACID SYNTHESIS; APOPTOSIS; AUTOLYSOSOME; AUTOPHAGOSOME; AUTOPHAGY; BINDING AFFINITY; CARDIOMYOPATHY; CELLULAR STRESS RESPONSE; CONGESTIVE CARDIOMYOPATHY; COPPER METABOLISM; DNA DAMAGE; DOWN REGULATION; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; ENERGY TRANSFER; FAST PROTEIN LIQUID CHROMATOGRAPHY; FENTON REACTION; FRIEDREICH ATAXIA; GENE EXPRESSION; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HEART VOLUME; HEME SYNTHESIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; IRON METABOLISM; IRON TRANSPORT; ISOTHERMAL TITRATION CALORIMETRY; MAGNETISM; MEMBRANE STRUCTURE; METAMORPHOSIS; MITOCHONDRIAL PERMEABILITY; MITOPHAGY; NONHUMAN; OLIGOMERIZATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SPINAL GANGLION; STRESS; TRANSLATION INITIATION; UPREGULATION;

ANIMALS; APOPTOSIS; CARDIOMYOPATHIES; FRIEDREICH ATAXIA; HUMANS; IRON-BINDING PROTEINS; MITOCHONDRIAL DISEASES; OXIDATIVE STRESS;

EID: 84880077900     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20130079     Document Type: Review

References (185)

1. Campuzano, V., Montermini, L., Lutz, Y., Cova, L., Hindelang, C., Jiralerspong, S., Trottier, Y., Kish, S. J., Faucheux, F., Trouillas, P. et al. (1997) Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum. Mol. Genet. 6, 1771-1780
2. Pandolfo, M. (2012) Friedreich ataxia. Handb. Clin. Neurol. 103, 275-294
3. Dürr, A., Cossee, M., Agid, Y., Campuzano, V., Mignard, C., Penet, C., Mandel, J.-L., Brice, A. and Koenig, M. (1996) Clinical and genetic abnormalities in patients with Friedreich's ataxia. N. Eng. J. Med. 335, 1169-1175
4. Cossée, M., Schmitt, M., Campuzano, V., Reutenauer, L., Moutou, C., Mandel, J. L. and Koenig, M. (1997) Evolution of the Friedreich's ataxia trinucleotide repeat expansion: founder effect and premutations. Proc. Natl. Acad. Sci. U.S.A. 94, 7452-7457
5. Labuda, M., Labuda, D., Miranda, C., Poirier, J., Soong, B. W., Barucha, N. E. and Pandolfo, M. (2000) Unique origin and specific ethnic distribution of the Friedreich ataxia GAA expansion. Neurology 54, 2322-2324
6. Schulz, J. B., Boesch, S., Bürk, K., Dürr, A., Giunti, P., Mariotti, C., Pousset, F., Schöls, L., Vankan, P. and Pandolfo, M. (2009) Diagnosis and treatment of Friedreich ataxia: a European perspective. Nat. Rev. Neurol. 5, 222-234
7. Campuzano, V., Montermini, L., Moltò, M. D., Pianese, L., Cossee, M., Cavalcanti, F., Monros, E., Rodius, F., Duclos, F., Monticelli, A. et al. (1996) Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271, 1423-1427
8. Chamberlain, S., Shaw, J., Rowland, A., Wallis, J., South, S., Nakamura, Y., von Gabain, A., Farrall, M. and Williamson, R. (1988) Mapping of mutation causing Friedreich's ataxia to human chromosome 9. Nature 334, 248-250
9. Santos, R., Lefevre, S., Sliwa, D., Seguin, A., Camadro, J.-M. and Lesuisse, E. (2010) Friedreich ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities. Antioxid. Redox Signaling 13, 651-690
10. Cossée, M., Dürr, A., Schmitt, M., Dahl, N., Trouillas, P., Allinson, P., Kostrzewa, M., Nivelon-Chevallier, A., Gustavson, K.-H., Kohlschütter, A. et al. (1999) Friedreich's ataxia: point mutations and clinical presentation of compound heterozygotes. Ann. Neurol. 45, 200-206
11. Sacca, F., Puorro, G., Antenora, A., Marsili, A., Denaro, A., Piro, R., Sorrentino, P., Pane, C., Tessa, A., Brescia Morra, V. et al. (2011) A combined nucleic acid and protein analysis in Friedreich ataxia: implications for diagnosis, pathogenesis and clinical trial design. PLoS ONE 6, e17627
12. Epplen, C., Epplen, J. T., Frank, G., Miterski, B., Santos, E. J. and Schols, L. (1997) Differential stability of the (GAA)n tract in the Friedreich ataxia (STM7 ) gene. Hum. Genet. 99, 834-836
13. Bidichandani, S. I., Ashizawa, T. and Patel, P. I. (1998) The GAA triplet-repeat expansion in Friedreich ataxia interferes with transcription and may be associated with an unusual DNA structure. Am. J. Hum. Genet. 62, 111-121
14. Filla, A., De Michele, G., Cavalcanti, F., Pianese, L., Monticelli, A., Campanella, G. and Cocozza, S. (1996) The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. Am. J. Hum. Genet. 59, 554-560
15. Harding, A. E. (1981) Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain 104, 589-620
16. Galluzzi, L., Kepp, O., Trojel-Hansen, C. and Kroemer, G. (2012) Mitochondrial control of cellular life, stress, and death. Circ. Res. 111, 1198-1207
17. Richardson, D. R., Lane, D. J. R., Becker, E. M., Huang, M. L.-H., Whitnall, M., Rahmanto, Y. S., Sheftel, A. D. and Ponka, P. (2010) Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol. Proc. Natl. Acad. Sci. U.S.A. 107, 10775-10782
18. Huang, M. L.-H., Lane, D. J. R. and Richardson, D. R. (2011) Mitochondrial mayhem: the mitochondrion as a modulator of iron metabolism and its role in disease. Antioxid. Redox Signaling 15, 3003-3019
19. Lawen, A. and Lane, D. J. R. (2013) Mammalian iron homeostasis in health and disease: uptake, storage, transport and molecular mechanisms of action. Antioxid. Redox Signaling 18, 2473-2507
20. Lill, R., Hoffmann, B., Molik, S., Pierik, A. J., Rietzschel, N., Stehling, O., Uzarska, M. A., Webert, H., Wilbrecht, C. and Muhlenhoff, U. (2012) The role of mitochondria in cellular iron-sulfur protein biogenesis and iron metabolism. Biochim. Biophys. Acta 1823, 1491-1508
21. Huang, M. L.-H., Becker, E. M., Whitnall, M., Rahmanto, Y. S., Ponka, P. and Richardson, D. R. (2009) Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant. Proc. Natl. Acad. Sci. U.S.A. 106, 16381-16386
22. Richardson, D. R., Huang, M. L.-H., Whitnall, M., Becker, E. M., Ponka, P. and Suryo Rahmanto, Y. (2010) The ins and outs of mitochondrial iron-loading: the metabolic defect in Friedreich's ataxia. J. Mol. Med. 88, 323-329
23. Babcock, M., de Silva, D., Oaks, R., Davis-Kaplan, S., Jiralerspong, S., Montermini, L., Pandolfo, M. and Kaplan, J. (1997) Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science 276, 1709-1712
24. Mühlenhoff, U., Richhardt, N., Ristow, M., Kispal, G. and Lill, R. (2002) The yeast frataxin homolog Yfh1p plays a specific role in the maturation of cellular Fe/S proteins. Hum. Mol. Genet. 11, 2025-2036
25. Whitnall, M., Suryo Rahmanto, Y., Sutak, R., Xu, X., Becker, E. M., Mikhael, M. R., Ponka, P. and Richardson, D. R. (2008) The MCK mouse heart model of Friedreich's ataxia: alterations in iron-regulated proteins and cardiac hypertrophy are limited by iron chelation. Proc. Natl. Acad. Sci. U.S.A. 105, 9757-9762
26. Payne, M. R. (2011) The heart in Friedreich's ataxia: basic findings and clinical implications. Prog. Pediatr. Cardiol. 31, 103-109
27. Whitnall, M., Rahmanto, Y. S., Huang, M. L.-H., Saletta, F., Lok, H. C., Gutiérrez, L., Lázaro, F. J., Fleming, A. J., St Pierre, T. G., Mikhael, M. R. et al. (2012) Identification of nonferritin mitochondrial iron deposits in a mouse model of Friedreich ataxia. Proc. Natl. Acad. Sci. U.S.A. 109, 20590-20595
28. Gakh, O., Park, S., Liu, G., Macomber, L., Imlay, J. A., Ferreira, G. C. and Isaya, G. (2006) Mitochondrial iron detoxification is a primary function of frataxin that limits oxidative damage and preserves cell longevity. Hum. Mol. Genet. 15, 467-479
29. Lodi, R., Hart, P. E., Rajagopalan, B., Taylor, D. J., Crilley, J. G., Bradley, J. L., Blamire, A. M., Manners, D., Styles, P., Schapira, A. H. V. and Cooper, J. M. (2001) Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia. Ann. Neurol. 49, 590-596
30. Maring, J. R. and Croarkin, E. (2007) Presentation and progression of Friedreich ataxia and implications for physical therapist examination. Phys. Ther. 87, 1687-1696
31. Cavadini, P., Adamec, J., Taroni, F., Gakh, O. and Isaya, G. (2000) Two-step processing of human frataxin by mitochondrial processing peptidase. Precursor and intermediate forms are cleaved at different rates. J. Biol. Chem. 275, 41469-41475
32. Condo, I., Ventura, N., Malisan, F., Rufini, A., Tomassini, B. and Testi, R. (2007) In vivo maturation of human frataxin. Hum. Mol. Genet. 16, 1534-1540
33. Schmucker, S., Argentini, M., Carelle-Calmels, N., Martelli, A. and Puccio, H. (2008) The in vivo mitochondrial two-step maturation of human frataxin. Hum. Mol. Genet. 17, 3521-3531
34. Vaubel, R. A. and Isaya, G. (2013) Iron-sulfur cluster synthesis, iron homeostasis and oxidative stress in Friedreich ataxia. Mol. Cell. Neurosci. 55, 50-61
35. Gibson, T. J., Koonin, E. V., Musco, G., Pastore, A. and Bork, P. (1996) Friedreich's ataxia protein: phylogenetic evidence for mitochondrial dysfunction. Trends Neurosci. 19, 465-468
36. Bencze, K. Z., Kalyan, C., Kondapalli, J. D., Cook, S., McMahon, C. M.-P., Pastor, N. and Stemmler, T. L. (2006) The structure and function of frataxin. Crit. Rev. Biochem. Mol. Biol. 41, 269-291
37. Lane, D. J. R. and Richardson, D. R. (2010) Frataxin, a molecule of mystery: trading stability for function in its iron-binding site. Biochem. J. 426, e1-e3
38. Yoon, T. and Cowan, J. A. (2003) Iron-sulfur cluster biosynthesis. Characterization of frataxin as an iron donor for assembly of [2Fe-2S] clusters in ISU-type proteins. J. Am. Chem. Soc. 125, 6078-6084
39. Yoon, T. and Cowan, J. A. (2004) Frataxin-mediated iron delivery to ferrochelatase in the final step of heme biosynthesis. J. Biol. Chem. 279, 25943-25946
40. Gabrielli, N., Ayte, J. and Hidalgo, E. (2012) Cells lacking Pfh1, a Fission yeast homolog of mammalian frataxin, display constitutive activation of the iron starvation response. J. Biol. Chem. 287, 43042-43051
41. Li, K., Besse, E. K., Ha, D., Kovtunovych, G. and Rouault, T. A. (2008) Iron-dependent regulation of frataxin expression: implications for treatment of Friedreich ataxia. Hum. Mol. Genet. 17, 2265-2273
42. Becker, E. M., Greer, J. M., Ponka, P. and Richardson, D. R. (2002) Erythroid differentiation and protoporphyrin IX down-regulate frataxin expression in Friend cells: characterization of frataxin expression compared to molecules involved in iron metabolism and hemoglobinization. Blood 99, 3813-3822
43. Pandolfo, M. and Pastore, A. (2009) The pathogenesis of Friedreich ataxia and the structure and function of frataxin. J. Neurol. 256, 9-17
44. Adamec, J., Rusnak, F., Owen, W. G., Naylor, S., Benson, L. M., Gacy, A. M. and Isaya, G. (2000) Iron-dependent self-assembly of recombinant yeast frataxin: implications for Friedreich ataxia. Am. J. Hum. Genet. 67, 549-562
45. Adinolfi, S., Trifuoggi, M., Politou, A. S., Martin, S. and Pastore, A. (2002) A structural approach to understanding the iron-binding properties of phylogenetically different frataxins. Hum. Mol. Genet. 11, 1865-1877
46. Cavadini, P., O'Neill, H. A., Benada, O. and Isaya, G. (2002) Assembly and iron-binding properties of human frataxin, the protein deficient in Friedreich ataxia. Hum. Mol. Genet. 11, 217-227
47. Aloria, K., Schilke, B., Andrew, A. and Craig, E. A. (2004) Iron-induced oligomerization of yeast frataxin homologue Yfh1 is dispensable in vivo. EMBO Rep. 5, 1096-1101
48. Levi, S., Corsi, B., Bosisio, M., Invernizzi, R., Volz, A., Sanford, D., Arosio, P. and Drysdale, J. (2001) A human mitochondrial ferritin encoded by an intronless gene. J. Biol. Chem. 276, 24437-24440
49. Drysdale, J., Arosio, P., Invernizzi, R., Cazzola, M., Volz, A., Corsi, B., Biasiotto, G. and Levi, S. (2002) Mitochondrial ferritin: a new player in iron metabolism. Blood Cells, Mol., Dis. 29, 376-383
50. Nie, G., Sheftel, A. D., Kim, S. F. and Ponka, P. (2005) Overexpression of mitochondrial ferritin causes cytosolic iron depletion and changes cellular iron homeostasis. Blood 105, 2161-2167
51. Arosio, P. and Levi, S. (2010) Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damage. Biochim. Biophys. Acta 1800, 783-792
52. Taketani, S. (1994) Molecular and genetic characterization of ferrochelatase. Stem Cells 12, 41-54
53. Gerber, J., Mühlenhoff, U. and Lill, R. (2003) An interaction between frataxin and Isu1/Nfs1 that is crucial for Fe/S cluster synthesis on Isu1. EMBO Rep. 4, 906-911
54. Adinolfi, S., Iannuzzi, C., Prischi, F., Pastore, C., Iametti, S., Martin, S. R., Bonomi, F. and Pastore, A. (2009) Bacterial frataxin CyaY is the gatekeeper of iron-sulfur cluster formation catalyzed by IscS. Nat. Struct. Mol. Biol. 16, 390-396
55. Rouault, T. A. and Tong, W.-H. (2005) Iron-sulphur cluster biogenesis and mitochondrial iron homeostasis. Nat. Rev. Mol. Cell Biol. 6, 345-351
56. Foury, F. and Cazzalini, O. (1997) Deletion of the yeast homologue of the human gene associated with Friedreich's ataxia elicits iron accumulation in mitochondria. FEBS Lett. 411, 373-377
57. Puccio, H., Simon, D., Cossee, M., Criqui-Filipe, P., Tiziano, F., Melki, J., Hindelang, C., Matyas, R., Rustin, P. and Koenig, M. (2001) Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat. Genet. 27, 181-186
58. Bradley, J. L., Homayoun, S., Hart, P. E., Schapira, A. H. V. and Cooper, J. M. (2004) Role of oxidative damage in Friedreich's ataxia. Neurochem. Res. 29, 561-567
59. Shvartsman, M. and Cabantchik, Z. I. (2012) Intracellular iron trafficking: role of cytosolic ligands. Biometals 25, 711-723
60. Foury, F. and Talibi, D. (2001) Mitochondrial control of iron homeostasis. A genome wide analysis of gene expression in a yeast frataxin-deficient strain. J. Biol. Chem. 276, 7762-7768
61. Yun, C. W., Tiedeman, J. S., Moore, R. E. and Philpott, C. C. (2000) Siderophore-iron uptake in Saccharomyces cerevisiae. Identification of ferrichrome and fusarinine transporters. J. Biol. Chem. 275, 16354-16359
62. Protchenko, O., Ferea, T., Rashford, J., Tiedeman, J., Brown, P. O., Botstein, D. and Philpott, C. C. (2001) Three cell wall mannoproteins facilitate the uptake of iron in Saccharomyces cerevisiae. J. Biol. Chem. 276, 49244-49250
63. Stadler, J. A. and Schweyen, R. J. (2002) The yeast iron regulon is induced upon cobalt stress and crucial for cobalt tolerance. J. Biol. Chem. 277, 39649-39654
64. Rutherford, J. C., Jaron, S. and Winge, D. R. (2003) Aft1p and Aft2p mediate iron-responsive gene expression in yeast through related promoter elements. J. Biol. Chem. 278, 27636-27643
65. Yamaguchi-Iwai, Y., Stearman, R., Dancis, A. and Klausner, R. D. (1996) Iron-regulated DNA binding by the AFT1 protein controls the iron regulon in yeast. EMBO J. 15, 3377-3384
66. Blaiseau, P. L., Lesuisse, E. and Camadro, J. M. (2001) Aft2p, a novel iron-regulated transcription activator that modulates, with Aft1p, intracellular iron use and resistance to oxidative stress in yeast. J. Biol. Chem. 276, 34221-34226
67. Rutherford, J. C., Ojeda, L., Balk, J., Muhlenhoff, U., Lill, R. and Winge, D. R. (2005) Activation of the iron regulon by the yeast Aft1/Aft2 transcription factors depends on mitochondrial but not cytosolic iron-sulfur protein biogenesis. J. Biol. Chem. 280, 10135-10140
68. Hentze, M. W., Muckenthaler, M. U., Galy, B. and Camaschella, C. (2010) Two to tango: regulation of mammalian iron metabolism. Cell 142, 24-38
69. Kim, B. E., Turski, M. L., Nose, Y., Casad, M., Rockman, H. A. and Thiele, D. J. (2010) Cardiac copper deficiency activates a systemic signaling mechanism that communicates with the copper acquisition and storage organs. Cell Metab. 11, 353-363
70. Fenton, H. J. H. (1894) Oxidation of tartaric acid in presence of iron. J. Chem. Soc., Trans. 65, 899-910
71. Papanikolaou, G. and Pantopoulos, K. (2005) Iron metabolism and toxicity. Toxicol. App. Pharmacol. 202, 199-211
72. Radisky, D. C., Babcock, M. C. and Kaplan, J. (1999) The yeast frataxin homologue mediates mitochondrial iron efflux. J. Biol. Chem. 274, 4497-4499
73. Rustin, P., von Kleist-Retzow, J.-C., Chantrel-Groussard, K., Sidi, D., Munnich, A. and Rötig, A. (1999) Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study. Lancet 354, 477-479
74. Emond, M., Lepage, G., Vanasse, M. and Pandolfo, M. (2000) Increased levels of plasma malondialdehyde in Friedreich ataxia. Neurology 55, 1752-1753
75. Schulz, J., Dehmer, T., Schöls, L., Mende, H., Hardt, C., Vorgerd, M., Bürk, K., Matson, W., Dichgans, J., Beal, M. and Bogdanov, M. (2000) Oxidative stress in patients with Friedreich ataxia. Neurology 55, 1719-1721
76. Seznec, H., Simon, D., Bouton, C., Reutenauer, L., Hertzog, A., Golik, P., Procaccio, V., Patel, M., Drapier, J.-C., Koenig, M. and Puccio, H. (2005) Friedreich ataxia: the oxidative stress paradox. Hum. Mol. Genet. 14, 463-474
77. Greer, S. N., Metcalf, J. L., Wang, Y. and Ohh, M. (2012) The updated biology of hypoxia-inducible factor. EMBO J. 31, 2448-2460
78. Oktay, Y., Dioum, E., Matsuzaki, S., Ding, K., Yan, L.-J., Haller, R. G., Szweda, L. I. and Garcia, J. A. (2007) Hypoxia-inducible factor 2α regulates expression of the mitochondrial aconitase chaperone protein frataxin. J. Biol. Chem. 287, 11750-11756
79. Guccini, I., Serio, D., Condo, I., Rufini, A., Tomassini, B., Mangiola, A., Maira, G., Anile, C., Fina, D., Pallone, F. et al. (2011) Frataxin participates to the hypoxia-induced response in tumors. Cell Death Dis. 2, 1-7
80. Casazza, F. and Morpurgo, M. (1996) The varying evolution of Friedreich's ataxia cardiomyopathy. Am. J. Cardiol. 77, 895-898
81. Kipps, A., Alexander, M., Colan, S. D., Gauvreau, K., Smoot, L., Crawford, L., Darras, B. T. and Blume, E. D. (2009) The longitudinal course of cardiomyopathy in Friedreich's ataxia during childhood. Pediatr. Cardiol. 30, 306-310
82. Bourke, T. and Keane, D. (2011) Friedreich's Ataxia: a review from a cardiology perspective. Iran. J. Med. Sci. 180, 799-805
83. Velasco-Sánchez, D., Aracil, A., Montero, R., Mas, A., Jiménez, L., O'Callaghan, M., Tondo, M., Capdevila, A., Blanch, J., Artuch, R. and Pineda, M. (2011) Combined therapy with idebenone and deferiprone in patients with Friedreich's ataxia. Cerebellum 10, 1-8
84. Sedlak, T. L., Chandavimol, M. and Straatman, L. (2004) Cardiac transplantation: a temporary solution for Friedreich's ataxia-induced dilated cardiomyopathy. J. Heart Lung Transplant. 23, 1304-1306
85. Koeppen, A. H. (2011) Friedreich's ataxia: pathology, pathogenesis, and molecular genetics. J. Neurol. Sci. 303, 1-12
86. Seznec, H., Simon, D., Monassier, L., Criqui-Filipe, P., Gansmuller, A., Rustin, P., Koenig, M. and Puccio, H. (2004) Idebenone delays the onset of cardiac functional alteration without correction of Fe-S enzymes deficit in a mouse model for Friedreich ataxia. Hum. Mol. Genet. 13, 1017-1024
87. Harding, H. P., Zhang, Y., Zeng, H., Novoa, I., Lu, P. D., Calfon, M., Sadri, N., Yun, C., Popko, B., Paules, R. et al. (2003) An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol. Cell 11, 619-633
88. Okada, K.-I., Minamino, T., Tsukamoto, Y., Liao, Y., Tsukamoto, O., Takashima, S., Hirata, A., Fujita, M., Nagamachi, Y., Nakatani, T. et al. (2004) Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis. Circulation 110, 705-712
89. Kroemer, G., Mariño, G. and Levine, B. (2010) Autophagy and the integrated stress response. Mol. Cell 40, 280-293
90. Sdek, P., Zhao, P., Wang, Y., Huang, C.-J., Ko, C. Y., Butler, P. C., Weiss, J. N. and MaClellan, W. R. (2011) Rb and p130 control cell cycle gene silencing to maintain the postmitotic phenotype in cardiac myocytes. J. Cell Biol. 194, 407-423
91. Sabbah, H. N. (1999) Apoptotic cell death in heart failure. Cardiovasc. Res. 45, 704-712
92. Knaapen, M. W. M., Davies, M. J., De Bie, M., Haven, A. J., Martinet, W. and Kockx, M. M. (2001) Apoptotic versus autophagic cell death in heart failure. Cardiovasc. Res. 51, 304-312
93. Hein, S., Arnon, E., Kostin, S., Schönburg, M., Elsässer, A., Polyakova, V., Bauer, E. P., Klövekorn, W.-P. and Schaper, J. (2003) Progression from compensated hypertrophy to failure in the pressure-overloaded human heart. Circulation 107, 984-991
94. Cossée, M., Puccio, H., Gansmuller, A., Koutnikova, H., Dierich, A., LeMeur, M., Fischbeck, K., Dollé, P. and Koenig, M. (2000) Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation. Hum. Mol. Genet. 9, 1219-1226
95. Santos, M. M., Ohshima, K. and Pandolfo, M. (2001) Frataxin deficiency enhances apoptosis in cells differentiating into neuroectoderm. Hum. Mol. Genet. 10, 1935-1944
96. Simon, D., Seznec, H., Gansmuller, A., Carelle, N., Weber, P., Metzger, D., Rustin, P., Koenig, M. and Puccio, H. (2004) Friedreich ataxia mouse models with progressive cerebellar and sensory ataxia reveal autophagic neurodegeneration in dorsal root ganglia. J. Neurosci. 24, 1987-1995
97. Wong, A., Yang, J., Cavadini, P., Gellera, C., Lonnerdal, B., Taroni, F. and Cortopassi, G. (1999) The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis. Hum. Mol. Genet. 8, 425-430
98. Ravichandran, K. S. (2011) Beginnings of a good apoptotic meal: the find-me and eat-me signaling pathways. Immunity 35, 445-455
99. Lamarche, J., Côté, M. and Lemieux, B. (1980) The cardiomyopathy of Friedreich's ataxia morphological observations in 3 cases. Can. J. Neurol. Sci. 7, 389-396
100. Larnaout, A., Belal, S., Zouari, M., Fki, M., Ben Hamida, C., Goebel, H., Ben Hamida, M. and Hentati, F. (1997) Friedreich's ataxia with isolated vitamin E deficiency: a neuropathological study of a Tunisian patient. Acta Neuropathol. 93, 633-637
101. Brunk, U. T. and Terman, A. (2002) Lipofuscin: mechanisms of age-related accumulation and influence on cell function. Free Radic. Biol. Med. 33, 611-619
102. Keller, J. N., Dimayuga, E., Chen, Q., Thorpe, J., Gee, J. and Ding, Q. (2004) Autophagy, proteasomes, lipofuscin, and oxidative stress in the aging brain. Int. J. Biochem. Cell Biol. 36, 2376-2391
103. Martinet, W., Knaapen, M. W., Kockx, M. and De Meyer, G. R. (2007) Autophagy in cardiovascular disease. Trends Mol. Med. 13, 482-491
104. Eisenberg-Lerner, A., Bialik, S., Simon, H. U. and Kimchi, A. (2009) Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ. 16, 966-975
105. Nanduri, S., Rahman, F., Williams, B. R. G. and Qin, J. (2000) A dynamically tuned double-stranded RNA binding mechanism for the activation of antiviral kinase PKR. EMBO J. 19, 5567-5574
106. McEwen, E., Kedersha, N., Song, B., Scheuner, D., Gilks, N., Han, A., Chen, J.-J., Anderson, P. and Kaufman, R. J. (2005) Heme-regulated inhibitor kinase-mediated phosphorylation of eukaryotic translation initiation factor 2 inhibits translation, induces stress granule formation, and mediates survival upon arsenite exposure. J. Biol. Chem. 280, 16925-16933
107. Chen, J.-J. (2007) Regulation of protein synthesis by the heme-regulated eIF2α kinase: relevance to anemias. Blood 109, 2693-2699
108. Kilberg, M. S., Shan, J. and Su, N. (2009) ATF4-dependent transcription mediates signaling of amino acid limitation. Trends Endocrinol. Metab. 20, 436-443
109. Kaufman, R. J. (1999) Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev. 13, 1211-1233
110. Baird, T. D. and Wek, R. C. (2012) Eukaryotic initiation factor 2 phosphorylation and translational control in metabolism. Adv. Nutr. 3, 307-321
111. Kimball, S. R., Horetsky, R. L., Ron, D., Jefferson, L. S. and Harding, H. P. (2003) Mammalian stress granules represent sites of accumulation of stalled translation initiation complexes. Am. J. Physiol. Cell Physiol. 284, C273-C284
112. Anderson, P. and Kedersha, N. (2008) Stress granules: the Tao of RNA triage. Trends Biochem. Sci. 33, 141-150
113. Ameri, K. and Harris, A. L. (2008) Activating transcription factor 4. Int. J. Biochem. Cell Biol. 40, 14-21
114. Tallóczy, Z., Jiang, W., Virgin, IV, H. W., Leib, D. A., Scheuner, D., Kaufman, R. J., Eskelinen, E.-L. and Levine, B. (2002) Regulation of starvation- and virus-induced autophagy by the eIF2α kinase signaling pathway. Proc. Natl. Acad. Sci. U.S.A. 99, 190-195
115. Kouroku, Y., Fujita, E., Tanida, I., Ueno, T., Isoai, A., Kumagai, H., Ogawa, S., Kaufman, R. J., Kominami, E. and Momoi, T. (2007) ER stress (PERK/eIF2α phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation. Cell Death Differ. 14, 230-239
116. Huang, M. L.-H., Sivagurunathan, S., Ting, S., Jansson, P. J., Austin, C. J. D., Kelly, M., Semsarian, C., Zhang, D. and Richardson, D. R. (2013) Molecular and functional alterations in a mouse cardiac model of Friedreich's ataxia: activation of the integrated stress response, eIF2α phosphorylation and the induction of downstream targets. Am. J. Pathol., in the press
117. Bowers, A. J., Scully, S. and Boylan, J. F. (2003) SKIP3, a novel Drosophila tribbles ortholog, is overexpressed in human tumors and is regulated by hypoxia. Oncogene 22, 2823-2835
118. Fu, H. Y., Okada, K.-I., Liao, Y., Tsukamoto, O., Isomura, T., Asai, M., Sawada, T., Okuda, K., Asano, Y., Sanada, S. et al. (2010) Ablation of C/EBP homologous protein attenuates endoplasmic reticulum-mediated apoptosis and cardiac dysfunction induced by pressure overload. Circulation 122, 361-369
119. Ohoka, N., Yoshii, S., Hattori, T., Onozaki, K. and Hayashi, H. (2005) TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell death. EMBO J. 24, 1243-1255
120. Yang, Y.-P., Liang, Z.-Q., Gu, Z.-L. and Qin, Z.-H. (2005) Molecular mechanism and regulation of autophagy. Acta Pharmacol. Sin. 26, 1421-1434
121. Murrow, L. and Debnath, J. (2013) Autophagy as a stress-response and quality-control mechanism: implications for cell injury and human disease. Annu. Rev. Phytopathol. 24, 105-137
122. Nishida, K., Kyoi, S., Yamaguchi, O., Sadoshima, J. and Otsu, K. (2008) The role of autophagy in the heart. Cell Death Differ. 16, 31-38
123. Kubli, D. A. and Gustafsson, A. B. (2012) Mitochondria and mitophagy: the yin and yang of cell death control. Circ. Res. 111, 1208-1221
124. Elsässer, A., Vogt, A. M., Nef, H., Kostin, S., Möllmann, H., Skwara, W., Bode, C., Hamm, C. and Schaper, J. (2004) Human hibernating myocardium is jeopardized by apoptotic and autophagic cell death. J. Am. Coll. Cardiol. 43, 2191-2199
125. Gustafsson, Å.B. and Gottlieb, R. A. (2009) Autophagy in ischemic heart disease. Circ. Res. 104, 150-158
126. Gottlieb, R. A. and Mentzer, Jr, R. M. (2012) Autophagy: an affair of the heart. Heart Fail. Rev., doi:10.1007/s10741-012-9367-2
127. Mizushima, N., Yoshimori, T. and Levine, B. (2010) Methods in mammalian autophagy research. Cell 140, 313-326
128. Denton, D., Shravage, B., Simin, R., Baehrecke, E. H. and Kumar, S. (2010) Larval midgut destruction in Drosophila: not dependent on caspases but suppressed by the loss of autophagy. Autophagy 6, 163-165
129. Mijaljica, D., Prescott, M. and Devenish, R. J. (2010) Mitophagy and mitoptosis in disease processes. Methods Mol. Biol. 648, 93-106
130. Gomes, L. C. and Scorrano, L. (2012) Mitochondrial morphology in mitophagy and macroautophagy. Biochim. Biophys. Acta 1833, 205-212
131. Ashrafi, G. and Schwarz, T. L. (2013) The pathways of mitophagy for quality control and clearance of mitochondria. Cell Death Differ. 20, 31-42
132. Beaulaton, J. and Lockshin, R. A. (1977) Ultrastructural study of the normal degeneration of the intersegmental muscles of Antheraea polyphemus and Manduca sexta (Insecta, Lepidoptera) with particular reference to cellular autophagy. J. Morphol. 154, 39-57
133. Sandoval, H., Thiagarajan, P., Dasgupta, S. K., Schumacher, A., Prchal, J. T., Chen, M. and Wang, J. (2008) Essential role for Nix in autophagic maturation of erythroid cells. Nature 454, 232-235
134. Pua, H. H., Guo, J., Komatsu, M. and He, Y.-W. (2009) Autophagy is essential for mitochondrial clearance in mature T lymphocytes. J. Immunol. 182, 4046-4055
135. Saelens, X., Festjens, N., Walle, L. V., van Gurp, M., van Loo, G. and Vandenabeele, P. (2004) Toxic proteins released from mitochondria in cell death. Oncogene 23, 2861-2874
136. Schaper, J., Meiser, E. and Stammler, G. (1985) Ultrastructural morphometric analysis of myocardium from dogs, rats, hamsters, mice, and from human hearts. Circ. Res. 56, 377-391
137. Kawai, C., Kato, S., Takashima, M., Fujiwara, H. and Haebara, H. (2000) Heart disease in Friedreich's ataxia: observation of a case for half a century. Jpn. Circ. J. 64, 229-236
138. Gallagher, C. L., Waclawik, A. J., Beinlich, B. R., Harding, C. O., Pauli, R. M., Poirer, J., Pandolfo, M. and Salamat, M. S. (2002) Friedreich's ataxia associated with mitochondrial myopathy: clinicopathologic report. J. Child Neurol. 17, 453-456
139. Lamarche, J., Luneau, C. and Lemieux, B. (1982) Ultrastructural observations on spinal ganglion biopsy in Friedreich's ataxia: a preliminary report. Can. J. Neurol. Sci. 9, 137-139
140. Terman, A., Kurz, T., Gustafsson, B. and Brunk, U. T. (2008) The involvement of lysosomes in myocardial aging and disease. Curr. Cardiol. Rev. 4, 107-115
141. Cohn, J. N., Ferrari, R. and Sharpe, N. (2000) Cardiac remodeling: concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J. Am. Coll. Cardiol. 35, 569-582
142. Kostin, S., Pool, L., Elsässer, A., Hein, S., Drexler, H. C. A., Arnon, E., Hayakawa, Y., Zimmermann, R., Bauer, E., Klövekorn, W.-P. and Schaper, J. (2003) Myocytes die by multiple mechanisms in failing human hearts. Circ. Res. 92, 715-724
143. Shimomura, H., Terasaki, F., Hayashi, T., Kitaura, Y., Isomura, T. and Suma, H. (2001) Autophagic degeneration as a possible mechanism of myocardial cell death in dilated cardiomyopathy. Jpn. Circ. J. 65, 965-968
144. Yan, L., Vatner, D. E., Kim, S.-J., Ge, H., Masurekar, M., Massover, W. H., Yang, G., Matsui, Y., Sadoshima, J. and Vatner, S. F. (2005) Autophagy in chronically ischemic myocardium. Proc. Natl. Acad. Sci. U.S.A. 102, 13807-13812
145. Gustafsson, A. B. and Gottlieb, R. A. (2008) Recycle or die: the role of autophagy in cardioprotection. J. Mol. Cell. Cardiol. 44, 654-661
146. Shizukuda, Y. and Buttrick, P. M. (2002) Subtype specific roles of β-adrenergic receptors in apoptosis of adult rat ventricular myocytes. J. Mol. Cell. Cardiol. 34, 823-831
147. Xiang, Y. and Kobilka, B. K. (2003) Myocyte adrenoceptor signaling pathways. Science 300, 1530-1532
148. Nakai, A., Yamaguchi, O., Takeda, T., Higuchi, Y., Hikoso, S., Taniike, M., Omiya, S., Mizote, I., Matsumura, Y., Asahi, M. et al. (2007) The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat. Med. 13, 619-624
149. Kuzman, J. A., O'Connell, T. D. and Gerdes, A. M. (2007) Rapamycin prevents thyroid hormone-induced cardiac hypertrophy. Endocrinology 148, 3477-3484
150. Beugnet, A., Tee, A. R., Taylor, P. M. and Proud, C. G. (2003) Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability. Biochem. J. 372, 555-566
151. Ravikumar, B., Vacher, C., Berger, Z., Davies, J. E., Luo, S., Oroz, L. G., Scaravilli, F., Easton, D. F., Duden, R., O'Kane, C. J. and Rubinsztein, D. C. (2004) Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 36, 585-595
152. Matsui, Y., Takagi, H., Qu, X., Abdellatif, M., Sakoda, H., Asano, T., Levine, B. and Sadoshima, J. (2007) Distinct roles of autophagy in the heart during ischemia and reperfusion. Circ. Res. 100, 914-922
153. Vigliano, C. A., Cabeza Meckert, P. M., Diez, M., Favaloro, L. E., Cortés, C., Fazzi, L., Favaloro, R. R. and Laguens, R. P. (2011) Cardiomyocyte hypertrophy, oncosis, and autophagic vacuolization predict mortality in idiopathic dilated cardiomyopathy with advanced heart failure. J. Am. Coll. Cardiol. 57, 1523-1531
154. Akazawa, H., Komazaki, S., Shimomura, H., Terasaki, F., Zou, Y., Takano, H., Nagai, T. and Komuro, I. (2004) Diphtheria toxin-induced autophagic cardiomyocyte death plays a pathogenic role in mouse model of heart failure. J. Biol. Chem. 279, 41095-41103
155. Takemura, G., Miyata, S., Kawase, Y., Okada, H., Maruyama, R. and Fujiwara, H. (2006) Autophagic degeneration and death of cardiomyocytes in heart failure. Autophagy 2, 212-214
156. Lawen, A. (2003) Apoptosis: an introduction. BioEssays 25, 888-896
157. Galluzzi, L., Vitale, I., Abrams, J. M., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., Dawson, T. M., Dawson, V. L., El-Deiry, W. S., Fulda, S. et al. (2012) Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ. 19, 107-120
158. Elmore, S. (2007) Apoptosis: a review of programmed cell death. Toxicol. Pathol. 35, 495-516
159. Norbury, C. J. and Hickson, I. D. (2001) Cellular responses to DNA damage. Annu. Rev. Pharmacol. Toxicol. 41, 367-401
160. Tang, D., Lotze, M. T., Kang, R. and Zeh, H. J. (2011) Apoptosis promotes early tumorigenesis. Oncogene 30, 1851-1854
161. Locksley, R. M., Killeen, N. and Lenardo, M. J. (2001) The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104, 487-501
162. Wilson, N. S., Dixit, V. and Ashkenazi, A. (2009) Death receptor signal transducers: nodes of coordination in immune signaling networks. Nat. Immunol. 10, 348-355
163. Kroemer, G., Galluzzi, L. and Brenner, C. (2007) Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 87, 99-163
164. Goldschneider, D. and Mehlen, P. (2010) Dependence receptors: a new paradigm in cell signaling and cancer therapy. Oncogene 29, 1865-1882
165. Barr, P. J. and Tomei, L. D. (1994) Apoptosis and its role in human disease. Nat. Biotechnol. 12, 487-493
166. Bennett, M. R. (2002) Apoptosis in the cardiovascular system. Heart 87, 480-487
167. Kang, P. M. and Izumo, S. (2000) Apoptosis and heart failure: a critical review of the literature. Circ. Res. 86, 1107-1113
168. Yue, T.-L., Ma, X.-L., Wang, X., Romanic, A. M., Liu, G.-l., Louden, C., Gu, J.-L., Kumar, S., Poste, G., Ruffolo, R. R. and Feuerstein, G. Z. (1998) Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol. Circ. Res. 82, 166-174
169. Nishigaki, K., Minatoguchi, S., Seishima, M., Asano, K., Noda, T., Yasuda, N., Sano, H., Kumada, H., Takemura, M., Noma, A. et al. (1997) Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure. J. Am. Coll. Cardiol. 29, 1214-1220
170. Bialik, S., Cryns, V. L., Drincic, A., Miyata, S., Wollowick, A. L., Srinivasan, A. and Kitsis, R. N. (1999) The mitochondrial apoptotic pathway is activated by serum and glucose deprivation in cardiac myocytes. Circ. Res. 85, 403-414
171. Koglin, J., Granville, D. J., Glysing-Jensen, T., Mudgett, J. S., Carthy, C. M., McManus, B. M. and Russell, M. E. (1999) Attenuated acute cardiac rejection in NOS2-/- recipients correlates with reduced apoptosis. Circulation 99, 836-842
172. Narula, J., Pandey, P., Arbustini, E., Haider, N., Narula, N., Kolodgie, F. D., Dal Bello, B., Semigran, M. J., Bielsa-Masdeu, A., Dec, G. W. et al. (1999) Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc. Natl. Acad. Sci. U.S.A. 96, 8144-8149
173. Adams, J. W., Pagel, A. L., Means, C. K., Oksenberg, D., Armstrong, R. C. and Brown, J. H. (2000) Cardiomyocyte apoptosis induced by Gαq signaling is mediated by permeability transition pore formation and activation of the mitochondrial death pathway. Circ. Res. 87, 1180-1187
174. Kang, P. M., Haunstetter, A., Aoki, H., Usheva, A. and Izumo, S. (2000) Morphological and molecular characterization of adult cardiomyocyte apoptosis during hypoxia and reoxygenation. Circ. Res. 87, 118-125
175. Misao, J., Hayakawa, Y., Ohno, M., Kato, S., Fujiwara, T. and Fujiwara, H. (1996) Expression of Bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction. Circulation 94, 1506-1512
176. Liu, L., Azhar, G., Gao, W., Zhang, X. and Wei, J. Y. (1998) Bcl-2 and Bax expression in adult rat hearts after coronary occlusion: age-associated differences. Am. J. Physiol.: Regul., Integr. Comp. Physiol. 275, R315-R322
177. Condorelli, G., Morisco, C., Stassi, G., Notte, A., Farina, F., Sgaramella, G., de Rienzo, A., Roncarati, R., Trimarco, B. and Lembo, G. (1999) Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left ventricular adaptations to chronic pressure overload in the rat. Circulation 99, 3071-3078
178. Brocheriou, V., Hagège, A. A., Oubenaïssa, A., Lambert, M., Mallet, V. O., Duriez, M., Wassef, M., Kahn, A., Menasché, P. and Gilgenkrantz, H. (2000) Cardiac functional improvement by a human Bcl-2 transgene in a mouse model of ischemia/reperfusion injury. J. Gene Med. 2, 326-333
179. Puccio, H. (2007) Conditional mouse models for Friedreich ataxia, a neurodegenerative disorder associating cardiomyopathy. Handb. Exp. Pharmacol. 178, 365-375
180. Ristow, M., Mulder, H., Pomplun, D., Schulz, T. J., Muller-Schmehl, K., Krause, A., Fex, M., Puccio, H., Muller, J. and Isken, F. (2003) Frataxin deficiency in pancreatic islets causes diabetes due to loss of β cell mass. J. Clin. Invest. 112, 527-534
181. Bayot, A., Santos, R., Camadro, J. M. and Rustin, P. (2011) Friedreich's ataxia: the vicious circle hypothesis revisited. BMC Med. 9, 112
182. Yaoita, H., Ogawa, K., Maehara, K. and Maruyama, Y. (1998) Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation 97, 276-281
183. Holly, T. A., Drincic, A., Byun, Y., Nakamura, S., Harris, K., Klocke, F. J. and Cryns, V. L. (1999) Caspase inhibition reduces myocyte cell death induced by myocardial ischemia and reperfusion in vivo. J. Mol. Cell. Cardiol. 31, 1709-1715
184. Müllauer, L., Gruber, P., Sebinger, D., Buch, J., Wohlfart, S. and Chott, A. (2001) Mutations in apoptosis genes: a pathogenetic factor for human disease. Mutat. Res., Rev. Mutat. Res. 488, 211-231
185. Liu, L., Feng, D., Chen, G., Chen, M., Zheng, Q., Song, P., Ma, Q., Zhu, C., Wang, R., Qi, W. et al. (2012) Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nat. Cell Biol. 14, 177-185